Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cell transplantation in heart failure management].

Jean-Thomas Vilquin1, Jean-Pierre Marolleau

  • 1Inserm U.582, Institut de Myologie, Groupe hospitalier Pitié-Salpêtrière, Bâtiment Babinski, 75651 Paris Cedex 13, France. jt.vilquin@myologie.chups.jussieu.fr

Medecine Sciences : M/S
|August 27, 2004
PubMed
Summary

Cell transplantation offers a promising alternative for heart failure treatment, with ongoing clinical trials exploring various cell types like skeletal muscle cells (myoblasts) and stem cells to improve cardiac function and structure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracorporeal Photopheresis (ECP) for Refractory Lichenoid Disorders: A Retrospective Analysis of Efficacy and Long-Term Outcomes.

Journal of clinical apheresis·2026
Same author

B-Cell Differentiation of Human Hematopoietic Progenitors Is Efficiently Supported by Wharton Jelly-Derived Mesenchymal Stem Cells.

European journal of immunology·2026
Same author

Life-Threatening Thrombotic Events Revealing Systemic Lupus Erythematosus in a Patient with Chronic Myelomonocytic Leukaemia.

European journal of case reports in internal medicine·2026
Same author

Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia.

British journal of haematology·2025
Same author

Mesenchymal stromal cells conditioned by peripheral blood mononuclear cells exert enhanced immunomodulation capacities and alleviate a model of Myasthenia Gravis.

Stem cell research & therapy·2025
Same author

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

European journal of haematology·2025

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Biology

Context:

  • Heart failure is a growing public health concern with limited therapeutic options.
  • Cell transplantation is an emerging strategy to restore cardiac structure and function.
  • Current research focuses on various cell types for cardiac repair.

Purpose:

  • To review different cell types and clinical trials for cell transplantation in heart failure.
  • To evaluate the efficacy and safety of cell-based therapies for improving cardiac outcomes.
  • To discuss the potential of cell therapy as a viable treatment for heart failure.

Summary:

  • Fetal/neonatal cardiomyocytes show functional success but face limitations.
  • Adult autologous cardiomyocytes derived from stem cells are being explored.

Related Experiment Videos

  • Endothelial progenitors and hematopoietic stem cells from bone marrow/peripheral blood are under investigation.
  • Skeletal muscle progenitor cells (myoblasts) have demonstrated functional improvement in preclinical models and early-phase clinical trials.
  • Ongoing clinical trials assess safety and efficacy, with potential side effects noted.

    • Impact:

    • Cell therapy holds significant potential for treating heart failure, a condition with unmet medical needs.
    • Successful clinical trials could lead to new therapeutic standards for cardiac regeneration.
    • Further research and high-quality clinical data are crucial for establishing cell therapy's role in heart failure management.